We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

This study has been terminated.
(The DSMB recommended that the study be stopped as a result of concerns regarding safety and intolerability and insufficient evidence of efficacy.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00803868
First Posted: December 8, 2008
Last Update Posted: July 24, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Friedreich's Ataxia Research Alliance
Pfizer
Information provided by (Responsible Party):
University of South Florida
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)